10 Biggest Antidepressant Drug Companies In 2017

Page 7 of 11

5. Bristol Myers Squibb Co. (NYSE:BMY)

Annual Revenue – $19.4 billion

Ranking fifth on our list of 10 biggest antidepressant drug companies in 2017 is Bristol Myers Squibb Co. (NYSE:BMY), a global biopharmaceutical company. The U.S. is Bristol Myers Squibb Co. (NYSE:BMY)’s largest market followed by Europe and rest of the world. Its drug Abilify is an antipsychotic agent for the treatment of schizophrenia, bipolar mania disorder, and major depressive disorder. It is one of the best-selling antidepressants in the market today in collaboration with the Japanese pharmaceutical company Otsuka as the alliance partner.

 

Follow Bristol Myers Squibb Co (NYSE:BMY)

Page 7 of 11